Medical Director/Senior Medical Director, Patient Safety & Risk Management

The Opportunity:

The Medical Director, Patient Safety & Risk Management at Relay Therapeutics will serve as the Global Medical Safety Lead (GSL) and provides strategic and medical leadership for the safety surveillance and risk management of Relay Therapeutic assigned products throughout the product lifecycle. This role is responsible for the evaluation, interpretation, and communication of safety information; signal detection and management; benefit-risk assessment; and development of risk minimization strategies to ensure patient safety and regulatory compliance. In addition, the GSL will support the medical review of individual case safety reports and safety surveillance activities as needed for assigned Relay Therapeutic products. The GSL will lead the cross functional Safety Management Team in the evaluation of safety signals and implementation of risk minimization activities for Relay Therapeutic products.

We are seeking a safety physician, who thrives in a dynamic, agile biotech environment. Reporting to the Executive Director, Patient Safety & Risk Management, this individual serve as a key collaborator and leader in cross functional clinical program teams, including Clinical Development, Clinical Operations, Biostats, Data Management and Regulatory Affairs. The successful candidate will play a critical role in advancing the development of transformative therapies by providing medical safety expertise.

Your Role:

Your Background:

Estimated Salary Range: [$201,000 - $351,000].

The range provided above is based on what we believe to be a reasonable estimate for this job at the time of posting. Actual base salary will depend on a number of factors, including but not limited to, a candidate’s education, experience, skills and location.

#BP1

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. We have built a world-class team of leading experts from each of these disciplines, and they are driven by a deep collaboration at every step of our drug discovery process.

Our team is equal parts fearless and relentless, with a shared passion for working collaboratively in intellectually stimulating environments. If you’re excited by the challenge of putting protein motion at the heart of drug discovery and passionate about making a difference in the lives of patients, join us!